rs763239856

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PP2PP3_Moderate

The NM_001378452.1(ITPR1):​c.4083C>A​(p.Phe1361Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

ITPR1
NM_001378452.1 missense

Scores

10
6
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 3.39
Variant links:
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PP2
Missense variant in the ITPR1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 44 curated pathogenic missense variants (we use a threshold of 10). The gene has 31 curated benign missense variants. Gene score misZ: 5.5951 (above the threshold of 3.09). Trascript score misZ: 6.2026 (above the threshold of 3.09). GenCC associations: The gene is linked to spinocerebellar ataxia type 15/16, aniridia-cerebellar ataxia-intellectual disability syndrome, spinocerebellar ataxia type 29.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.869

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITPR1NM_001378452.1 linkc.4083C>A p.Phe1361Leu missense_variant Exon 33 of 62 ENST00000649015.2 NP_001365381.1
ITPR1NM_001168272.2 linkc.4038C>A p.Phe1346Leu missense_variant Exon 32 of 61 NP_001161744.1 Q14643-2
ITPR1NM_001099952.4 linkc.4056C>A p.Phe1352Leu missense_variant Exon 33 of 59 NP_001093422.2 Q14643-3B4DER3Q59H91
ITPR1NM_002222.7 linkc.4011C>A p.Phe1337Leu missense_variant Exon 32 of 58 NP_002213.5 Q14643-4B4DER3B4DGH1Q59H91

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITPR1ENST00000649015.2 linkc.4083C>A p.Phe1361Leu missense_variant Exon 33 of 62 NM_001378452.1 ENSP00000497605.1 Q14643-1
ITPR1ENST00000354582.12 linkc.4056C>A p.Phe1352Leu missense_variant Exon 33 of 62 5 ENSP00000346595.8 A0A3F2YNW8
ITPR1ENST00000648266.1 linkc.4056C>A p.Phe1352Leu missense_variant Exon 33 of 62 ENSP00000498014.1 A0A3B3IU04
ITPR1ENST00000650294.1 linkc.4038C>A p.Phe1346Leu missense_variant Exon 32 of 61 ENSP00000498056.1 A0A3B3ITU8
ITPR1ENST00000443694.5 linkc.4038C>A p.Phe1346Leu missense_variant Exon 32 of 61 1 ENSP00000401671.2 Q14643-2
ITPR1ENST00000648309.1 linkc.4011C>A p.Phe1337Leu missense_variant Exon 30 of 59 ENSP00000497026.1 Q14643-5
ITPR1ENST00000357086.10 linkc.4056C>A p.Phe1352Leu missense_variant Exon 33 of 59 1 ENSP00000349597.4 Q14643-3
ITPR1ENST00000456211.8 linkc.4011C>A p.Phe1337Leu missense_variant Exon 32 of 58 1 ENSP00000397885.2 Q14643-4
ITPR1ENST00000648038.1 linkc.1893C>A p.Phe631Leu missense_variant Exon 14 of 42 ENSP00000497872.1 A0A3B3ITQ1
ITPR1ENST00000648431.1 linkc.1383C>A p.Phe461Leu missense_variant Exon 11 of 39 ENSP00000498149.1 A0A3B3IU05
ITPR1ENST00000648212.1 linkc.990C>A p.Phe330Leu missense_variant Exon 9 of 39 ENSP00000498022.1 A0A3B3IU13

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152160
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000120
AC:
3
AN:
249286
Hom.:
0
AF XY:
0.00000739
AC XY:
1
AN XY:
135240
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000265
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000103
AC:
15
AN:
1461662
Hom.:
0
Cov.:
31
AF XY:
0.0000124
AC XY:
9
AN XY:
727122
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000117
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152160
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74332
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000329
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
May 15, 2024
Athena Diagnostics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity. (http://gnomad.broadinstitute.org) Polyphen and MutationTaster yielded discordant predictions regarding whether this amino acid change is damaging to the protein. -

Jul 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1337 of the ITPR1 protein (p.Phe1337Leu). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with ITPR1-related conditions. ClinVar contains an entry for this variant (Variation ID: 435538). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ITPR1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Uncertain:1
Jun 29, 2016
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Uncertain:1
Feb 22, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.4011C>A (p.F1337L) alteration is located in exon 32 (coding exon 30) of the ITPR1 gene. This alteration results from a C to A substitution at nucleotide position 4011, causing the phenylalanine (F) at amino acid position 1337 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.23
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.89
.;.;.;.;.;.;D;.;.;.
Eigen
Uncertain
0.24
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.89
D;D;D;D;D;D;D;D;.;D
M_CAP
Pathogenic
0.36
D
MetaRNN
Pathogenic
0.87
D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.84
D
MutationAssessor
Uncertain
2.2
.;.;.;.;.;.;M;.;.;.
PrimateAI
Pathogenic
0.88
D
PROVEAN
Pathogenic
-4.8
D;D;.;D;.;.;.;.;D;.
REVEL
Pathogenic
0.76
Sift
Benign
0.12
T;T;.;T;.;.;.;.;T;.
Sift4G
Benign
0.17
T;T;.;T;.;.;.;.;T;.
Polyphen
1.0
.;.;.;.;.;.;D;.;.;.
Vest4
0.65
MutPred
0.69
.;.;.;.;.;.;Gain of MoRF binding (P = 0.2545);.;.;.;
MVP
0.84
MPC
1.9
ClinPred
0.98
D
GERP RS
4.1
Varity_R
0.65
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs763239856; hg19: chr3-4735227; API